Glass House Brands GLAS
NYSE GLAS
$9.52 -0.25 (-2.56%)
At close: Aug 20, 2026 · 4:00 PM EDT

Glass House Brands (GLAS) Liabilities and Shareholders Equity (2020 - 2026)

Glass House Brands (GLAS) posted quarterly Liabilities and Shareholders Equity of $325.4 million for Q1 2026, up 4.42% year-over-year from $311.6 million in Q1 2025, and up 2.13% quarter-over-quarter from $318.6 million in Q4 2025.

Glass House Brands (GLAS) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $325.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 4.42% year-over-year to $325.4 million; the TTM figure through Mar 2026 stood at $1.3 billion (up 4.64% YoY), while the FY2025 annual figure was $318.6 million, up 2.59% from the prior year.
  • Liabilities and Shareholders Equity advanced to $325.4 million in Q1 2026 per GLAS's latest filing, from $318.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $350.6 million in Q4 2022 and bottomed at $273.2 million in Q1 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $318.2 million across 5 years, with a median of $318.6 million in 2025.
  • On a YoY basis, Liabilities and Shareholders Equity climbed as much as 6041.02% in 2022 and fell as far as 61.84% in 2022.
  • Glass House Brands' Liabilities and Shareholders Equity stood at $350.6 million in 2022, then fell by 13.36% to $303.8 million in 2023, then grew by 2.21% to $310.5 million in 2024, then advanced by 2.59% to $318.6 million in 2025, then advanced by 2.13% to $325.4 million in 2026.
  • Business Quant data shows GLAS's Liabilities and Shareholders Equity at $325.4 million in Q1 2026, $318.6 million in Q4 2025, and $319.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 39.86 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 6.18 Bn
10 Glass House Brands 837.25 Mn 818.69 Mn 15.77 Mn 313.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 325.35 Mn
Dec 31, 2025 318.56 Mn
Sep 30, 2025 319.82 Mn
Jun 30, 2025 334.56 Mn
Mar 31, 2025 311.59 Mn
Dec 31, 2024 310.50 Mn
Sep 30, 2024 312.73 Mn
Jun 30, 2024 305.84 Mn
Mar 31, 2024 295.25 Mn
Dec 31, 2023 303.78 Mn
Sep 30, 2023 341.59 Mn
Jun 30, 2023 324.60 Mn
Mar 31, 2023 324.70 Mn
Dec 31, 2022 350.63 Mn
Sep 30, 2022 349.56 Mn
Jun 30, 2022 307.25 Mn
Mar 31, 2022 273.15 Mn
Dec 31, 2021 5.71 Mn
Sep 30, 2021 258.56 Mn
Jun 30, 2021 203.47 Mn